The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line envafolimab in combination with recombinant human endostatin and chemotherapy for advanced squamous non-small cell lung cancer: Updated results from a prospective, single-arm, multicenter phase II study.
 
Lian Liu
No Relationships to Disclose
 
Yanguo Liu
No Relationships to Disclose
 
Jie Liu
No Relationships to Disclose
 
Xueyan Yu
No Relationships to Disclose
 
Song Li
No Relationships to Disclose
 
Jian Wang
No Relationships to Disclose
 
Yingjie Zhang
No Relationships to Disclose
 
Shuai Guo
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Yi Xie
No Relationships to Disclose
 
Liyun Zhou
No Relationships to Disclose
 
Yuanyuan Zhao
No Relationships to Disclose